This study looks at how well and safely Afimkibart (RO7790121) works for people with moderate to severe atopic dermatitis (AD), a skin condition that causes itchy and inflamed skin. To join, participants must have had an AD diagnosis for at least a year and be using a simple, additive-free moisturizer daily. They should not have other skin issues or be using certain treatments like specific creams or pills for skin conditions. The study also excludes those with active infections or immune system problems.
- The study requires regular visits and ongoing use of a simple moisturizer.
- Certain skin treatments and medications cannot be used during the study.
- Participants should have a confirmed diagnosis of moderate to severe AD.